Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Hepcidin in Saliva and Its Utility as a Diagnostic Marker for Iron Deficiency

NCT03816813 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.

NCT NCT03816813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03816813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Hepcidin in Saliva and Its Utility as a Diagnostic Marker for Iron Deficiency
Lead sponsor
Swiss Federal Institute of Technology
Phase
Observational
Overall status
Completed
Start date
February 4, 2019
Completion date
February 7, 2019
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepcidin, saliva